Oncological outcomes of breast cancer patients after planned IORT boost with low-kV x-rays: results of the TARGIT BQR prospective phase IV trial

The TARGIT BQR (boost quality registry) phase IV trial investigates clinical outcomes of breast cancer patients with standard external-beam radiotherapy (EBRT) of the whole breast and intraoperative radiotherapy (IORT) with low-kV x‑rays as an anticipated tumor bed boost in a real-world setting.

Guardado en:
Detalles Bibliográficos
Autores principales: Goerdt, Lukas (Autor) , Pömsl, Janina (Autor) , Kraus-Tiefenbacher, Uta (Autor) , Brück, Viktoria (Autor) , Kaiser, Christina (Autor) , Keymer, Ralf (Autor) , Abo-Madyan, Yasser (Autor) , Fleckenstein, Katharina (Autor) , Berlit, Sebastian (Autor) , Tuschy, Benjamin (Autor) , Sütterlin, Marc (Autor) , Wenz, Frederik (Autor) , Sperk, Elena (Autor)
Formato: Article (Journal)
Lenguaje:inglés
Publicado: 19 May 2025
In: Strahlentherapie und Onkologie
Year: 2026, Volumen: 202, Número: 2, Pages: 169-177
ISSN:1439-099X
DOI:10.1007/s00066-025-02412-0
Acceso en línea:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00066-025-02412-0
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00066-025-02412-0
Enlace del recurso
Notas de Autor:Lukas Goerdt, Janina Pömsl, Uta Kraus-Tiefenbacher, Viktoria Brück, Christina Kaiser, Ralf Keymer, Yasser Abo-Madyan, Katharina Fleckenstein, Sebastian Berlit, Benjamin Tuschy, Marc Sütterlin, Frederik Wenz, Elena Sperk
Descripción
Sumario:The TARGIT BQR (boost quality registry) phase IV trial investigates clinical outcomes of breast cancer patients with standard external-beam radiotherapy (EBRT) of the whole breast and intraoperative radiotherapy (IORT) with low-kV x‑rays as an anticipated tumor bed boost in a real-world setting.
Notas:Gesehen am 01.09.2025
Descripción Física:Online Resource
ISSN:1439-099X
DOI:10.1007/s00066-025-02412-0